Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Category: Rare and Autoinflammatory Diseases

EULAR 2025 highlights…

EULAR 2025 Highlights – Rare and Autoinflammatory diseases

18 Jul 202518 Jul 2025
A WINDOW OF OPPORTUNITY IN STILL’S DISEASE: THE EARLY INTRODUCTION OF IL-1 INHIBITORS FOR ACHIEVING CLINICAL INACTIVE DISEASE Abstract format and assignment number: Poster 0377 Presenting author: S. Bindoli (Italy)…
Rare and Autoinflammatory Diseases

EULAR 2025: Do Not Miss – Rare and autoinflammatory diseases

1 Jun 20251 Jun 2025
Saverio La BellaSaverio is a resident in Pediatric Rheumatology at the IRCCS Istituto Giannina Gaslini in Genova, Italy. His research interests include autoinflammatory diseases, the application of AI tools, and…
ACR Highlights…

ACR Convergence 2024 Highlights – Rare and Autoinflammatory diseases

19 Dec 202419 Dec 2024
Damage associated with disease-specific events and diagnostic or therapeutic procedures is highly prevalent in IgG4-related disease Abstract format and assignment number: Poster 0286 Presenting author: J. Stone (US) Date: Saturday,…
ACR Congress Do Not Miss…

ACR Convergence 2024: Do Not Miss – Rare and autoinflammatory diseases

5 Nov 20246 Nov 2024
Guillermo Carvajal AlegriaGuillermo is an associate professor of rheumatology at the University of Tours and in the rheumatology department of the Tours University Hospital, France. His research interest are polymyalgia…
EULAR 2024 Highlights…

EULAR 2024 Highlights – Rare and Autoinflammatory diseases

21 Jul 202421 Jul 2024
Author: Francesca Crisafulli Jachiet et al. (OP0231) evaluated retrospectively the efficacy and safety of azacitidine (AZA) treatment in 57 VEXAS patients, including 50 with myelodysplastic syndrome (MDS) and 7 without, from the French national…
Rare and Autoinflammatory Diseases

EULAR 2024: Do Not Miss – Rare and autoinflammatory diseases

8 Jun 2024
Aleksandra Opinc-RosiakAleksandra is a trainee in rheumatology at the USK-WAM Hospital, research and teaching assistant at the Medical University of Lodz, Poland. Her major interests are idiopathic inflammatory myopathies, in…
Rare and Autoinflammatory Diseases

Rare & Autoinflammatory Diseases

29 May 202329 May 2023
Aleksandra Opinc-Rosiak Aleksandra is a trainee in rheumatology at the USK-WAM Hospital and research&teaching assistant at the Medical University of Lodz, Poland. Her major interests are idiopathic inflammatory myopathies, in…
Rare and Autoinflammatory Diseases

[ACR22] Rare and Autoinflammatory Diseases

29 Nov 20226 Dec 2022
Author: Francesca Crisafulli Direskeneli et al. (2231) retrospectively investigated the rate of new major organ involvement and/or relapses during follow-up in 440 patients with Behçet disease (BD) under immunosuppressive treatment…

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify
 

Loading Comments...